Sonoma Pharmaceuticals (SNOA) Institutional Ownership $2.38 -0.51 (-17.53%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sonoma Pharmaceuticals (NASDAQ:SNOA)CurrentInstitutional OwnershipPercentage1.95%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.93KNumber ofInstitutional Sellers(last 12 months)0 Get SNOA Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonoma Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNOA Institutional Buying and Selling by Quarter Remove Ads Sonoma Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/29/2024 Ground Swell Capital LLC10,400$32K0.0%N/A1.083% 11/16/2021 Squarepoint Ops LLC15,712$88K0.0%N/A0.751% 8/13/2021 Renaissance Technologies LLC92,167$677K0.0%-6.7%4.406% 8/13/2021 Geode Capital Management LLC30,181$221K0.0%N/A1.443% 8/13/2021 Vanguard Group Inc.27,975$205K0.0%+44.9%1.337% 5/13/2021 Renaissance Technologies LLC98,826$734K0.0%+7.7%4.758% 5/11/2021 Acadian Asset Management LLC6,026$45K0.0%-29.5%0.290% 2/10/2021 Renaissance Technologies LLC91,734$666K0.0%-3.2%4.421% (Data available from 1/1/2016 forward)Remove Ads SNOA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNOA shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonoma Pharmaceuticals shares: Ground Swell Capital LLC ($32K).Learn more on SNOA's institutional investors. What percentage of Sonoma Pharmaceuticals stock is owned by institutional investors? 1.95% of Sonoma Pharmaceuticals stock is owned by institutional investors. Learn more on SNOA's institutional investor holdings. Which institutional investors have been buying Sonoma Pharmaceuticals stock? The following institutional investors have purchased Sonoma Pharmaceuticals stock in the last 24 months: Ground Swell Capital LLC ($10.40K). How much institutional buying is happening at Sonoma Pharmaceuticals? Institutional investors have bought a total of 10,400 shares in the last 24 months. This purchase volume represents approximately $31.93K in transactions. Related Companies NanoViricides Institutional Ownership CEL-SCI Institutional Ownership Cognition Therapeutics Institutional Ownership Lisata Therapeutics Institutional Ownership Lipocine Institutional Ownership 23andMe Institutional Ownership Calidi Biotherapeutics Institutional Ownership Eagle Pharmaceuticals Institutional Ownership IN8bio Institutional Ownership Mannatech Institutional Ownership This page (NASDAQ:SNOA) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.